Loading...
Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $145.6K Total Trade · DGFT Verified
Ashtanga Vaidyam Ayurvedics is an Indian pharmaceutical exporter with a total trade value of $145.6K across 5 products in 1 therapeutic categories. Based on 583 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Taila ($106.5K), Arishta ($15.3K), Kwatha ($13.0K).
Ashtanga Vaidyam Ayurvedics, also known as K.S. Varier's Ashtanga Ayurvedics Private Limited, was established in 1999 and is headquartered in Trichy, Tamil Nadu, India. The company specializes in the manufacturing of Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. As a private limited entity, it is classified under the Corporate Identification Number (CIN) U24233TN1999PTC041899. The authorized capital stands at ₹2.00 crore, with a paid-up capital of ₹1.85 crore. The latest available financial data indicates that the company is active and operational. For more information, the official website is ashtangam.com.
Ashtanga Vaidyam Ayurvedics operates across 1 therapeutic categories, with Ayurvedic & Herbal Products (100.0%), representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.
Ayurvedic & Herbal Products
5 products · 100.0% · $145.6K
Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories.
| # | Product | Category | Export Value | Shipments | Market Share | Rank |
|---|---|---|---|---|---|---|
| 1 | Taila | Ayurvedic & Herbal Products | $106.5K | 326 | 1.4% |
Headquarters, ownership, manufacturing facilities, and key leadership
Ashtanga Vaidyam Ayurvedics, also known as K.S. Varier's Ashtanga Ayurvedics Private Limited, was established in 1999 and is headquartered in Trichy, Tamil Nadu, India. The company specializes in the manufacturing of Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. As a private limited entity, it is classified under the Corporate Identification Number (CIN) U24233TN1999PTC041899. The authorized capital stands at ₹2.00 crore, with a paid-up capital of ₹1.85 crore. The latest available financial data indicates that the company is active and operational. For more information, the official website is ashtangam.com.
Ashtanga Vaidyam Ayurvedics operates manufacturing facilities in Trichy, Tamil Nadu, India. The company specializes in the production of Ayurvedic pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding plant capacities and specialized manufacturing processes are not publicly disclosed. The facilities are designed to adhere to stringent quality standards, ensuring the efficacy and safety of their products.
| 2 | Arishta | Ayurvedic & Herbal Products | $15.3K | 63 | 1.1% | 10 |
| 3 | Kwatha | Ayurvedic & Herbal Products | $13.0K | 88 | 2.4% | 12 |
| 4 | Asava | Ayurvedic & Herbal Products | $5.8K | 44 | 1.3% | 9 |
| 5 | Ghrita | Ayurvedic & Herbal Products | $5.1K | 62 | 1.1% | 3 |
Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories with a total export value of $145.6K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.
Shipment-level records, pricing & buyer contacts for Ashtanga Vaidyam Ayurvedics.
Request DemoThe leadership team at Ashtanga Vaidyam Ayurvedics includes:
These individuals play pivotal roles in steering the company's strategic direction and operations.
Regulated market presence, emerging market penetration, and geographic strategy
Ashtanga Vaidyam Ayurvedics has a presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations, such as Taila, Arishta, Kwatha, Asava, and Ghrita, with a total export value of $146,000 USD across 583 shipments. These products are classified under the Ayurvedic & Herbal Products category. Specific details regarding regulatory filings, approvals, and market access status in these regions are not publicly disclosed.
Ashtanga Vaidyam Ayurvedics has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's commitment to quality and adherence to international standards have facilitated its entry into these regions. While specific details regarding WHO prequalification and other certifications enabling access to these markets are not publicly disclosed, the company's global footprint indicates a strategic approach to market diversification.
The company's export portfolio is entirely concentrated in the Ayurvedic & Herbal Products category, with the top five products accounting for 100% of the export value. This indicates a high level of portfolio concentration, which may expose the company to risks associated with market fluctuations and regulatory changes in the Ayurvedic sector. Diversifying the product portfolio and exploring new therapeutic categories could mitigate such risks and enhance the company's market resilience.
FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record
Specific details regarding Ashtanga Vaidyam Ayurvedics' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. The company's export data indicates a presence in the U.S. market, suggesting compliance with FDA regulations for the export of Ayurvedic pharmaceutical formulations. However, without publicly available records, a comprehensive assessment of the company's FDA status cannot be conducted.
Ashtanga Vaidyam Ayurvedics' commitment to quality is evident in its adherence to international standards. While specific details regarding WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed, the company's global export activities suggest compliance with these standards. However, without publicly available records, a comprehensive assessment of the company's certifications cannot be conducted.
Ashtanga Vaidyam Ayurvedics operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Specific details regarding export No Objection Certificates (NOCs) and other regulatory approvals are not publicly disclosed. The company's export data indicates adherence to Indian regulatory standards for the export of Ayurvedic pharmaceutical formulations.
As of March 2026, there are no publicly available records indicating any Form 483 observations, warning letters, or import alerts issued to Ashtanga Vaidyam Ayurvedics. The absence of such records suggests that the company maintains a compliant status with regulatory authorities. However, without publicly available records, a comprehensive assessment of the company's regulatory history cannot be conducted.
Market share comparison, key differentiators, and strategic analysis
Ashtanga Vaidyam Ayurvedics operates in the Ayurvedic pharmaceutical sector, competing with other manufacturers of Ayurvedic formulations. While specific market share data and a head-to-head analysis are not publicly available, the company's export data indicates a presence in various international markets, suggesting a competitive position in the global Ayurvedic pharmaceutical industry. The company's focus on quality and adherence to international standards contribute to its competitive edge.
Ashtanga Vaidyam Ayurvedics' key differentiators include its longstanding heritage in Ayurvedic medicine, established in 1936, and its commitment to quality and innovation. The company's product portfolio, consisting of over 300 formulations, reflects its dedication to providing a diverse range of Ayurvedic solutions. Additionally, the company's focus on research and development for innovative natural therapies and its collaborations with leading firms in the field further distinguish it in the market.
Ashtanga Vaidyam Ayurvedics' current strategic direction focuses on the manufacturing and export of Ayurvedic pharmaceutical formulations. The company's emphasis on quality, research and development, and adherence to international standards positions it well in the global market. Future strategic initiatives may include diversifying the product portfolio, exploring new therapeutic categories, and expanding into additional international markets to enhance growth and mitigate risks associated with market concentration.
Track record assessment, certifications to verify, and pre-order checks
Ashtanga Vaidyam Ayurvedics has demonstrated a consistent track record in the export of Ayurvedic pharmaceutical formulations, with a total export value of $146,000 USD across 583 shipments. The company's reliability is indicated by its established presence in various international markets and its adherence to quality standards. However, specific details regarding export volume consistency and other reliability indicators are not publicly disclosed.
Importers should verify the following certifications when considering products from Ashtanga Vaidyam Ayurvedics:
To verify these certifications, importers can request copies of the certificates directly from the company or consult the respective regulatory bodies' official databases.
When conducting due diligence on Ashtanga Vaidyam Ayurvedics, importers should consider the following steps:
Red flags to watch for include expired or invalid certifications, inconsistent financial records, quality complaints, and negative client feedback. Recommended pre-order checks involve obtaining third-party audits and consulting industry peers.
Ashtanga Vaidyam Ayurvedics exports 5 pharmaceutical products across 1 therapeutic categories. The top exports are Taila ($106.5K), Arishta ($15.3K), Kwatha ($13.0K), Asava ($5.8K), Ghrita ($5.1K). Total export value is $145.6K.
Ashtanga Vaidyam Ayurvedics's total pharmaceutical export value is $145.6K, based on 583 verified shipments recorded in Indian Customs (DGFT) data.
Ashtanga Vaidyam Ayurvedics exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 5 products).
Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Verify manufacturer licensing, GMP certification, and export registration with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Products Tracked
1 therapeutic categories
Expert-Reviewed
By pharmaceutical trade specialists
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.